Bacterial Profiles and Their Associated Factors of Urinary Tract Infection and Detection of Extended Spectrum Beta-Lactamase Producing Gram-Negative Uropathogens Among Patients with Diabetes Mellitus at Dessie Referral Hospital, Northeastern Ethiopia

References

• Federation ID, Atlas I; International Diabetes Federation. IDF Diabetes atlas. 6th ed. International Diabetes Federation: Brussels, Belgium; 2013.
   Google Scholar
• World Health Organization. Global Report on Diabetes 2016. 2016. ISBN 978 92 4 156525 7.
   Google Scholar
• Bishu KG, Jenkins C, Yebyo HG, Atsbha M, Wubayehu T, Gebregziabher M. Diabetes in Ethiopia: a systematic review of prevalence, risk factors, complications, and cost. Obes Med. 2019;15:100132. doi:10.1016/j.obmed.2019.100132
   Google Scholar
• Walsh C, Collyns T. The pathophysiology of urinary tract infections. Surgery. 2017;35(6):293–298. doi:10.1016/j.mpsur.2017.03.007
   Google Scholar
• Simkhada R. Urinary tract infection and antibiotic sensitivity pattern among diabetics. Nepal Med Coll J. 2013;15(1):1–4.
   PubMedGoogle Scholar
• Bagir GS, Haydardedeoglu FE, Colakoglu S, Bakiner OS, Ozsahin KA, Ertorer ME. Urinary tract infection in diabetes: susceptible organisms and antibiogram patterns in an outpatient clinic of a tertiary health care center. Med Science. 2019.
   Google Scholar
• Sewify M, Nair S, Warsame S, et al. Prevalence of urinary tract infection and antimicrobial susceptibility among diabetic patients with controlled and uncontrolled glycemia in Kuwait. J Diabetes Res. 2016.
   PubMedGoogle Scholar
• Aswani SM, Chandrashekar U, Shivashankara K, Pruthvi B. Clinical profile of urinary tract infections in diabetics and non-diabetics. Australas Med J. 2014;7(1):29.
   PubMedGoogle Scholar
• Chiţă T, Timar B, Muntean D, et al. Urinary tract infections in Romanian patients with diabetes: prevalence, etiology, and risk factors. Ther Clin Risk Manag. 2017;13:1.
   PubMed Web of Science ®Google Scholar
• Geerlings SE. Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int J Antimicrob Agents. 2008;31:54–57. doi:10.1016/j.ijantimicag.2007.07.042
   PubMed Web of Science ®Google Scholar
• Shah MA, Kassab YW, Anwar MF, et al. Prevalence and associated factors of urinary tract infections among diabetic patients. Health Sci J. 2019;13(2):1–5.
   Google Scholar
• Anejo-Okopi JA, Okojokwu OJ, Ramyil SM-C, et al. Bacterial and antibiotic susceptibility pattern of urinary tract infection isolated from asymptomatic and symptomatic diabetic patients attending tertiary hospital in Jos, Nigeria. Trends Med. 2017;17(1). doi:10.15761/TiM.1000108
   Google Scholar
• Hamdan HZ, Kubbara E, Adam AM, Hassan OS, Suliman SO, Adam I. Urinary tract infections and antimicrobial sensitivity among diabetic patients at Khartoum, Sudan. Ann Clin Microbiol Antimicrob. 2015;14(1):26. doi:10.1186/s12941-015-0082-4
   PubMedGoogle Scholar
• Abate D, Kabew G, Urgessa F, Meaza D. Bacterial etiologies, antimicrobial susceptibility patterns and associated risk factors of urinary tract infection among diabetic patients attending diabetic clinics in Harar, Eastern Ethiopia. East Afr Med J Health Biomed Sci. 2017;1(2):11–20.
   Google Scholar
• Yeshitela B, Gebre-Selassie S, Feleke Y. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in tikur anbessa specialized University Hospital, Addis Ababa, Ethiopia. Ethiop Med J. 2012;50(3):239–249.
   PubMedGoogle Scholar
• Worku S, Derbie A, Sinishaw MA, Adem Y, Biadglegne F. Prevalence of bacteriuria and antimicrobial susceptibility patterns among diabetic and nondiabetic patients attending at Debre Tabor Hospital, Northwest Ethiopia. Int J Microbiol. 2017;2017:1–8. doi:10.1155/2017/5809494
   Google Scholar
• Gutema T, Weldegebreal F, Marami D, Teklemariam Z. Prevalence, antimicrobial susceptibility pattern, and associated factors of urinary tract infections among adult diabetic patients at Metu Karl Heinz Referral Hospital, Southwest Ethiopia. Int J Microbiol. 2018;2018:1–7. doi:10.1155/2018/7591259
   Web of Science ®Google Scholar
• Woldemariam HK, Geleta DA, Tulu KD, et al. Common uropathogens and their antibiotic susceptibility pattern among diabetic patients. BMC Infect Dis. 2019;19(1):43. doi:10.1186/s12879-018-3669-5
   PubMedGoogle Scholar
• Al-Qaseer A, Abdul-wahab B, Abbas O. Bacteriological finding of urinary tract infection in diabetic patients. Int J Adv Res. 2014;2(10):274–279.
   Google Scholar
• Krishnakumar S, Rajan RA, Babu MM, Bai VDM. Antimicrobial susceptibility pattern of extended spectrum of beta lactamase (ESBL) producing uropathogens from pregnant women. Indian J Med Healthcare. 2012;1(8):189–192.
   Google Scholar
• Kateregga JN, Kantume R, Atuhaire C, Lubowa MN, Ndukui JG. Phenotypic expression and prevalence of ESBL-producing Enterobacteriaceae in samples collected from patients in various wards of Mulago Hospital, Uganda. BMC Pharmacol Toxicol. 2015;16(1):14. doi:10.1186/s40360-015-0013-1
   PubMedGoogle Scholar
• Thapa R, Lamichhane P, Banjara MR, Acharya GP. Prevalence of extended spectrum beta lactamase producing uropathogens in pregnant women. Asian J Pharm Clin Res. 2015;8(1):207–210.
   Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 27th Ed. CLSI Supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey R, et al. Multidrug‐resistant, extensively drug‐resistant and pandrug‐resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Nigussie D, Amsalu A. Prevalence of uropathogen and their antibiotic resistance pattern among diabetic patients. Turk J Urol. 2017;43(1):85. doi:10.5152/tud.2016.86155
   PubMedGoogle Scholar
• Yismaw G, Asrat D, Woldeamanuel Y, Unakal CG. Urinary tract infection: bacterial etiologies, drug resistance profile and associated risk factors in diabetic patients attending Gondar University Hospital, Gondar, Ethiopia. Euro J Exp Bio. 2012;2(4):889–898.
   Google Scholar
• Kebamo S, Dabso R, Deressa A, Gebrie M. Urinary tract infection: bacterial etiologies, drug resistance profile and associated risk factors among diabetic patients attending Nekemte Referral Hospital, Ethiopia. Am J Curr Microbiol. 2017;5(1):19–31.
   Google Scholar
• Nabaigw BI, Mwambi B, Okiria J, Oyet C. Common uropathogens among diabetic patients with urinary tract infection at Jinja Regional Referral Hospital, Uganda. Afr J Lab Med. 2018;7(1):1–3.
   Google Scholar
• Sharma V, Gupta V, Mittal M. Prevalence of uropathogens in diabetic patients and their antimicrobial susceptibility pattern. Natl J Lab Med. 2012;1(1):26–28.
   Google Scholar
• Kumar Jha P, Baral R, Khanal B. Prevalence of uropathogens in diabetic patients and their susceptibility pattern at a tertiary care center in Nepal-a retrospective study. Int J Bio Lab Sci. 2014;3:29–34.
   Google Scholar
• Janifer J, Geethalakshmi S, Satyavani K, Viswanathan V. Prevalence of lower urinary tract infection in South Indian type 2 diabetic subjects. Indian J Nephrol. 2009;19(3):107. doi:10.4103/0971-4065.57107
   PubMedGoogle Scholar
• Mama M, Manilal A, Gezmu T, Kidanewold A, Gosa F, Gebresilasie A. Prevalence and associated factors of urinary tract infections among diabetic patients in Arba Minch Hospital, Arba Minch province, South Ethiopia. Turk J Urol. 2019;45(1):56. doi:10.5152/tud.2018.32855
   PubMed Web of Science ®Google Scholar
• Pragash DS, Girija S, Sekar U, Rayapu V, Sheriff D. Uropathogens and diabetes mellitus-a perspective. IOSR J Dent Med Sci. 2017;16(5):29–32. doi:10.9790/0853-1605052932
   Google Scholar
• Kumar D, Singh AK, Ali MR, Chander Y. Antimicrobial susceptibility profile of extended spectrum β-lactamase (ESBL) producing Escherichia coli from various clinical samples. Infect Dis. 2014;7:S13820.
   Google Scholar
• Wiles TJ, Kulesus RR, Mulvey MA. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol. 2008;85(1):11–19. doi:10.1016/j.yexmp.2008.03.007
   PubMed Web of Science ®Google Scholar
• Mulvey MA. Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol. 2002;4(5):257–271. doi:10.1046/j.1462-5822.2002.00193.x
   PubMed Web of Science ®Google Scholar
• Majeed HT, Aljanaby AAJ. Antibiotic susceptibility patterns and prevalence of some extended spectrum beta-lactamases genes in gram-negative bacteria isolated from patients infected with urinary tract infections in Al-Najaf City, Iraq. Avicenna J Med Biotechnol. 2019;11(2):192.
   PubMedGoogle Scholar
• Alebiosu C, Osinupebi O, Olajubu F. Significant asymptomatic bacteriuria among Nigerian type 2 diabetics. J Natl Med Assoc. 2003;95(5):344.
   PubMed Web of Science ®Google Scholar
• Alo M, Saidu A. Prevalence and antbiogram of bacterial isolates causing urinary tract infections at federal teaching hospital Abakaliki I (FETHA I). Microbiol Res J. 2015;403–417.
   Google Scholar
• Mubarak AA, Ashraf AM, El-hag M, et al. Prevalence of urinary tract infections among diabetes mellitus and non-diabetic patients attending a teaching hospital in Ajman, UAE. Gulf Med J. 2012;1(S1):s228–s232.
   Google Scholar
• Mulisa G, Selassie L, WT JG, Shiferew T, Zewdu A. Prevalence of extended spectrum beta-lactamase producing Enterobacteriaceae: a cross sectional study at Adama hospital, Adama, Ethiopia. J Emerg Infect Dis. 2016;1(1):1–6.
   Google Scholar
• Mulualem Y, Kasa T, Mekonnen Z, Suleman S. Occurrence of extended spectrum beta (b)-lactamases in multidrug resistant Escherichia coli isolated from a clinical setting in Jimma university specialized hospital, Jimma, southwest Ethiopia. East Afr J Public Health. 2012;9(2):58–61.
   PubMedGoogle Scholar
• Moyo SJ, Aboud S, Kasubi M, Lyamuya EF, Maselle SY. Antimicrobial resistance among producers and non-producers of extended spectrum beta-lactamases in urinary isolates at a tertiary Hospital in Tanzania. BMC Res Notes. 2010;3(1):348. doi:10.1186/1756-0500-3-348
   PubMedGoogle Scholar
• Legese MH, Weldearegay GM, Asrat D. Extended-spectrum beta-lactamase-and carbapenemase-producing Enterobacteriaceae among Ethiopian children. Infect Drug Resist. 2017;10:27. doi:10.2147/IDR.S127177
   PubMed Web of Science ®Google Scholar
• Shakya P, Shrestha D, Maharjan E, Sharma VK, Paudyal R. ESBL production among E. coli and Klebsiella spp. causing urinary tract infection: a hospital based study. Open Microbiol J. 2017;11(1):23. doi:10.2174/1874285801711010023
   PubMedGoogle Scholar
• Gebremariam G, Legese H, Woldu Y, Araya T, Hagos K, GebreyesusWasihun A. Bacteriological profile, risk factors and antimicrobial susceptibility patterns of symptomatic urinary tract infection among students of Mekelle University, northern Ethiopia. BMC Infect Dis. 2019;19(1):950. doi:10.1186/s12879-019-4610-2
   PubMedGoogle Scholar
• Al Yousef SA, Younis S, Farrag E, Moussa HS, Bayoumi FS, Ali AM. Clinical and laboratory profile of urinary tract infections associated with extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae. Ann Clin Lab Sci. 2016;46(4):393–400.
   PubMedGoogle Scholar
• Lee SY, Kotapati S, Kuti JL, Nightingale CH, Nicolau DP. Impact of extended-spectrum β-lactamase–producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol. 2006;27(11):1226–1232.
   PubMed Web of Science ®Google Scholar